Defective Medical Device
Claim Funding.

Defective medical device claim funding is case-based legal funding that may be available to qualifying represented claimants with pending civil claims involving an allegedly defective medical device. FCA reviews funding eligibility with counsel.

Potentially. FCA may review qualifying represented medical device claims case by case. Approval, amount, cost, terms and availability depend on the individual claim and jurisdiction.

Depending on the individual matter, qualifying represented claims may involve implantable devices, orthopedic devices, surgical devices, cardiac devices, recalled devices or other allegedly defective medical products.

No. A recall by itself does not establish that a claimant has a viable civil claim. The claimant's attorney determines the legal theories, evidence and remedies that may apply.

No. FCA does not make medical diagnoses or determine medical causation. FCA evaluates funding eligibility based on information about the pending claim that can be verified with counsel.

Applicants generally need to be represented by an attorney because FCA coordinates with counsel to verify the pending claim and relevant case information.

FCA's legal funding review focuses primarily on the underlying pending claim rather than traditional consumer credit underwriting. Eligibility is reviewed case by case.

Available funding varies by matter and may depend on anticipated recovery, alleged damages, available recovery sources, case status, existing advances and other case-specific factors.

Timing depends on the individual matter and how quickly the information required for funding review can be verified with counsel.

FCA reviews qualifying matters across its service network. Product liability law, funding availability and permitted terms vary by jurisdiction, so eligibility is determined for the individual claim.